Biobank study for neuromuscular disease samples
Part of Brain & nervous system clinical trials.
This study collects leftover tissue from muscle or nerve biopsies to build a biobank for future research on neuromuscular diseases. It may help improve diagnosis and treatment for conditions like yours.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be treated at Bordeaux University Hospital for a suspected neuromuscular disease.
- Adults and children of any gender can join.
- You have had or will have a muscle or nerve biopsy as part of your care.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is building a biobank (a secure research collection) from people with neuromuscular diseases, their families, or healthy volunteers. By joining, you help researchers study these conditions and improve future treatments.
This study compares people with neuromuscular disorders to healthy people using questionnaires and brain/neurological tests. It may help researchers understand how these conditions affect the brain and nervous system.
This study collects and stores biological samples (a “biobank”) from people with autoimmune cytopenia, so researchers can learn more about the condition. If you qualify, your samples may help future studies and improve care, and it’s based on voluntary consent.
This study collects biological samples to better understand what causes Noonan syndrome. If you qualify, your participation could help researchers learn how the condition works and guide future care.
This study collects tissue and blood samples from people with nerve or muscle disorders to help researchers learn more about these conditions. The goal is to build a bank of samples for future studies.
This study follows adults who have (or are being evaluated for) inflammatory muscle conditions to collect health data and genetic test information. It may help researchers better understand these diseases and improve future care.
Hear when a new Neuromuscular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.